New York State Psychiatric Institute
Clinical trials sponsored by New York State Psychiatric Institute, explained in plain language.
-
Can meditation keep kids off drugs? new study aims to find out
Prevention Not yet recruitingThis study tests a new mindfulness program called MINDS-UP to help prevent substance use in children and teens aged 10 to 14. Researchers will compare kids who do a sports-based prevention program alone to those who also learn mindfulness. The goal is to see if the program is pra…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Prevention
Last updated Apr 29, 2026 15:15 UTC
-
New study aims to boost job success for adults with OCD
Symptom relief Not yet recruitingThis study compares two types of job support for adults with obsessive-compulsive disorder (OCD) who are unemployed but want to work. All 40 participants will receive up to 12 sessions of a proven OCD therapy called exposure and response prevention. Half will also get a specializ…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC
-
Sleep therapy may boost brain resilience in memory loss
Knowledge-focused Not yet recruitingThis study looks at whether two sleep treatments—talk therapy for insomnia and a device that enhances deep sleep—can improve thinking skills and daily function in older adults with mild memory problems and poor sleep. Fifty participants aged 60-85 will be randomly assigned to one…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC
-
Brain scans reveal how ketamine fights suicidal thoughts in depressed patients
Knowledge-focused Not yet recruitingThis study looks at how stress and suicidal thoughts are linked in people with major depressive disorder, and how ketamine might help by affecting stress-related brain pathways. Researchers will use smartphone tracking and PET brain scans to monitor 12 participants. The goal is t…
Phase: PHASE4 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC
-
Brain scans reveal Cobenfy's inner workings in schizophrenia
Knowledge-focused Not yet recruitingThis study looks at how the drug Cobenfy changes dopamine activity in the brains of people with schizophrenia. Twelve participants will take Cobenfy for 5 weeks and get PET and MRI scans before and after treatment. The goal is to understand how the drug works, not to test if it i…
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC